Home Global Sensation! World's First Commercial Adaptive Optics Retinal Imaging System 'StellarScope®' Launches, Marking a Breakthrough in Ophthalmic Diagnostics

Global Sensation! World's First Commercial Adaptive Optics Retinal Imaging System 'StellarScope®' Launches, Marking a Breakthrough in Ophthalmic Diagnostics

Jan 05, 2024 19:52 CST Updated 19:52
Robotrak Technologies

Ophthalmic Medical Device R&D Developer

46c9b44cc4d07653116c32c162fa372e.png


A New Year Brings Renewal to All Things.Robotrak Technologies' Self-developed Adaptive Optics Fundus Imaging System - StarMirror®Successfully obtained the innovative medical device registration certificate issued by the Jiangsu Provincial Drug Administration, officially launched!This is another major milestone in the development of China's ophthalmic medical technology, marking that the innovation and R&D capabilities in the field of domestically produced ophthalmic medical equipment have reached new heights.


51bb43ecb452547e1aee3e9f8330a323.png

Adaptive Optics Fundus Imaging System - StarMirror®Scene Map


Adaptive Optics (AO) has been recognized as one of the most influential technologies in the field of ophthalmic imaging in the 21st century. However, research on adaptive optics systems has remained at the laboratory stage, unable to achieve miniaturization, commercialization, and large-scale clinical application. After years of dedication and deep cultivation in the field of adaptive optics technology, Robotrak Technologies has continuously innovated and launched the world's first commercially available adaptive optics retinal imaging system—StarMirror.®, increasing the lateral resolution of fundus images to 0.7 microns. It can be used for studying disease pathogenesis, ultra-early diagnosis, intervention, follow-up observation, and evaluation of innovative therapies such as gene and stem cell treatments. It is acclaimed as a cellular-level "Fundus In Vivo Biomicroscope"! StarLens®It will pave the way for an in-depth exploration of the microscopic world of the human eye and also build a bridge for research in brain science and systemic diseases.


c106fd6266fbe3f9a6515c3ac6934dba.png

3fdba311dc1a760341d7ce21b2410d93.png


Stellar Lens®The approval and market launch of the product is another demonstration of Robotrak Technologies' R&D strength, and it also signifies that domestically produced medical devices are gradually leading the trend of advanced global ophthalmic imaging technology, placing them at the forefront of the times! Adhering to the original mission of "Everyone deserves a clearer world," Robotrak Technologies is committed to creating first-in-class innovative ophthalmic products, serving every patient in need, and promoting global eye health development!


>>>>

About Robotrak Technologies

Robotrak Technologies Co., Ltd. is an ophthalmic innovation platform company catering to all age groups. Adhering to the original aspiration of "Everyone deserves a clearer world," and with the mission of "Technological innovation, affordable healthcare, rooted in China, with a global perspective," the company is committed to providing innovative solutions in areas such as diagnosis and treatment of fundus diseases, myopia prevention and control for adolescents, functional contact lenses, digital ophthalmic healthcare, and customized research equipment. Robotrak Technologies possesses core technologies including adaptive optics, optical design and precision machining, optical measurement and imaging, eye-tracking, precise laser positioning, artificial intelligence, image algorithms, and material processes, creating two major business segments: ophthalmic devices and contact lenses, covering markets in healthcare, consumer products, and scientific research.